Newly Diagnosed

Treatment & Care

Solid pseudopapillary neoplasm of the pancreas: Very rare and is info because someone asked:…

MedMaven

Solid pseudopapillary neoplasm of the pancreas: Very rare and is info because someone asked:

Solid pseudopapillary neoplasm of the pancreas: a single institution experience of 14 cases

Solid pseudopapillary neoplasm of pancreas (SPN) is a rare entity; therefore proper diagnosis, evaluation and formulation of treatment protocols is difficult. A total of 14 cases were diagnosed and treated at our institute over a 10-year period (1992–2002). ...

Comments (2)

No. 1-2

MedMaven

Editor

Jan 29

Not sure but the http://cancerconnect.com group has some members

http://cancerconnect.com

Samantha98

Jan 29

Hi @MedMaven I just wanted to let you know I did have a SPN. Do you know who asked about SPN? I'm trying to find individuals like me

Pancreatic Cancer

FEATURED

COMMUNITY

Pancreatic Cancer Treatment and Management

Understand the role of surgery, chemotherapy and precision cancer medicines for treatment of pancreatic cancer.

Cancer Connect

by

Juvanta

Overview of Pancreatic Cancer

Symptoms, risk factors, diagnosis, screening and prevention of pancreatic cancer.

Cancer Connect

Drugs in Development for Advanced Pancreatic Cancer

BRCA, RAS, KRAS, NRG, ATM and other cancer causing mutations are being targeted with precision cancer medicines.

MedMaven

Treatment of Stage IV - Metastatic Pancreatic Cancer

Treatment is with precision medicines & chemotherapy - genomic biomarker testing should be performed in all patients.

Cancer Connect

A Global Phase 3 Study Investigating Cancer Stemness Inhibitor Napabucasin

A Global Phase 3 Study Investigating Cancer Stemness Inhibitor Napabucasin was stopped due to poor results

Cancer Connect

by

polisella

PARP Inhibitors Shows Promise as Treatment for Pancreatic Cancer

PARP Inhibitor Lynparza - first precision cancer medicine approved for treatment of pancreatic cancer.

Cancer Connect

BL- 8040 - A Novel CXCR4 Blocking Agent for Pancreatic Cancer

Triplet immunotherapy - BL-8040 combination shows promising responses in metastatic pancreatic cancer.

MedMaven

Early Activity in Pancreatic Cancer with Adavosertib

Experimental Gemzar-Adavosertib- Radiation combination promising for treatment of locally advanced pancreatic cancer.

MedMaven

NRG 1 Fusion Genes Can be Targeted with the MCLA-128 Bispecific Antibody

Responses to MCLA-128 reported in patients with pancreatic ductal adenocarcinoma and non-small cell lung cancer.

MedMaven

Pancreatic Cancer Screening, Early Detection and Prevention

The latest genetic-genomic advances defining who should undergo screening for the early detection of pancreatic cancer.

Cancer Connect

by

Eira